Ventyx biosciences to participate in the jefferies healthcare conference

Encinitas, calif., june 01, 2022 (globe newswire) -- ventyx biosciences, inc. (nasdaq: vtyx), (“ventyx”), a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a range of inflammatory diseases with significant unmet medical need, today announced that raju mohan, chief executive officer of ventyx, will provide a company overview during a fireside chat at the jefferies healthcare conference being held june 8-10, 2022.
VTYX Ratings Summary
VTYX Quant Ranking